Email Updates

You are here

Home

11 NOVEMBER 2022 VOLUME 24 ISSUE 45

Media Coverage

  • RIP Dawn Smith, an HIV Prevention Advocate and CDC Researcher

    The Office of Infectious Disease and HIV/AIDS Policy joins the rest of the HIV community in mourning the passing of Center for Disease Control and Prevention’s Dr. Dawn Smith. Many of us in this office were fortunate to work with Dr. Smith. She was an insightful leader and a friend. Her career as an epidemiologist, medical officer, and researcher in CDC’s Division of HIV Prevention (DHP) spanned decades and her myriad contributions to the field made a real difference in the lives of so many people.

    November 10, 2022
    General
    POZ Magazine

  • People Living With HIV Found To Have a Significantly Delayed Internal Body Clock

    People living with HIV have a significantly delayed internal body clock, consistent with the symptoms of jet lag, according to new findings reported by researchers from universities in South Africa and the UK. The findings, which have been published in the Journal of Pineal Research, may explain some of the health problems experienced by people with HIV, and guide research towards improving their quality of life.

    November 10, 2022
    General
    News Medical

  • This African Nation Just Hit an HIV Milestone

    Zimbabwe has hit and surpassed a global target for HIV testing and treatment.The country’s Ministry of Health and Child Care confirmed that 95 percent of the HIV-positive population in Zimbabwe has reached undetectable levels of the virus, reports New Ziana. That means these individuals cannot transmit the virus to others.

    November 10, 2022
    Treatment
    Plus Magazine

  • Living With COVID-19 and Preparing for Future Pandemics: Revisiting Lessons From the HIV Pandemic

    In April, 2020, just months into the COVID-19 pandemic, an international group of public health researchers published three lessons learned from the HIV pandemic for the response to COVID-19, which were to: anticipate health inequalities, create an enabling environment to support behavioural change, and engage a multidisciplinary effort. We revisit these lessons in light of more than 2 years’ experience with the COVID-19 pandemic.

    November 10, 2022
    General
    The Lancet HIV

  • SA Expected To Begin Piloting HIV Prevention Shot in Early 2023

    South Africa is expected to begin piloting the every-other-month HIV prevention shot early next year, according to the international medicine financing initiative Unitaid. New modeling released this week shows that the injection could prevent as many as 52,000 new HIV infections in the next two decades if rolled out nationally. But to be cost-effective in South Africa, the research suggests the price of the injection must fall to levels drugmaker ViiV Healthcare says are unrealistic.

    November 9, 2022
    PrEP
    Spotlight

  • An HIV Therapeutic Vaccine, aka a Cure, Inches Forward

    University of Oxford researchers completed a clinical trial that demonstrated the T-cell therapeutic HIV vaccine AELIX-002 had better control of the virus when antiretroviral therapy (ART) was temporarily halted. Mirage News reported that the study, whose full results were published in Nature Medicine, showed two-fifths of participants with no genetic background of spontaneous HIV control were able to stay off ART for the six months of supervised pause.

    November 9, 2022
    HIV Vaccine
    Plus Magazine

  • Commentary: Here’s One Positive From COVID-19 — It Could Give a Boost to HIV Self-Testing in Singapore

    The COVID-19 pandemic has changed our lives in ways too numerous to count. But not every effect has been a bad one. Massive disruptions to healthcare services aside, beneficial emerging trends have been accelerated: Greater access to telehealth, a better understanding of respiratory etiquette and hand hygiene as well as awareness of the importance of staying home when sick all have obvious advantages to public health.

    November 9, 2022
    General
    Today

  • Do People Who Inject Drugs Use HIV PrEP?

    Though it is highly effective at preventing HIV infection, pre-exposure prophylaxis (PrEP) is underutilized among injection drug users. Thus, investigators from the Boston University School of Medicine and Boston Medical Center sought to determine the prevalence of HIV PrEP among commercially insured individuals who use injection drugs.

    November 9, 2022
    PrEP
    Contagion Live

  • Lenacapavir Shows Continued Promise for People With Drug-Resistant HIV

    Lenacapavir, the first HIV capsid inhibitor, continues to demonstrate good efficacy for highly treatment-experienced people, including those with a low CD4 count or a high baseline viral load, according to further results from the CAPELLA study presented at the recent HIV Drug Therapy meeting in Glasgow.

    November 9, 2022
    General
    POZ Magazine

  • Dem Governor Signs Bill Punishing HIV Transmission With Prison

    Democratic governor Tom Wolf of Pennsylvania recently signed a bill into law that makes passing on a communicable disease a felony punishable by up to 10 years in prison. The new law, known as HB 103, charges a third-degree felony with up to seven years in prison and $15,000 in fines for those who “expel” saliva, blood, or any other bodily fluid on a police officer. The offense must be “intentional,” but that intention is usually left up for debate.

    November 9, 2022
    General
    Plus Magazine

  • PrEP Suitable for Pregnant Women, Safe, and Effective

    Pre-exposure prophylaxis (PrEP), an antiretroviral drug used by HIV-negative individuals to lessen their chance of contracting the virus, has been deemed both effective and safe by health experts in Zimbabwe. Dr Tariro Dianah Chawana Mutingwende, an HIV prevention researcher and expert from the University of Zimbabwe’s Clinical Trials Research Centre, told journalists at a recent Health Journalists Association of Zimbabwe (HeJAZ) online scientific café on HIV Reporting that PrEP is an effective method of preventing HIV transmission through unprotected sex.

    November 9, 2022
    PrEP
    Chronicle

  • HIV Injectable PrEP a Game-Changer

    Cabotegravir (CAB-LA) is a long-term HIV injectable pre-exposure prophylaxis (PrEP), which is expected to reduce the risk of getting HIV infection by 79 percent if compared to oral PrEP. Until Zimbabwe’s regulatory approval, only two high-income countries had given it regulatory approval.

    November 9, 2022
    PrEP
    The Sunday Mail

  • PrEP Chaos: How Central Europe Is Suffering From Inconsistent Guidelines, Random Access, and Healthcare Stigma

    The number of people able to access HIV pre-exposure prophylaxis (PrEP) in most countries of central Europe still numbers in the tens to hundreds of people rather than thousands, and there are no signs of immediate improvements, the recent Standard of Care for HIV and Co-infections in Europe meeting heard. The meeting is organised by the European AIDS Clinical Society (EACS) and was held in Brussels.

    November 8, 2022
    PrEP
    aidsmap

  • Study Highlights Need for Person-Centered HIV Prevention Efforts

    A new analysis published by PLOS Medicine examines a new set of HIV prevention targets to be achieved by 2025 to facilitate progress toward a sustainable development target by 2030 through the United Nations General Assembly and other partners. Although the number of new HIV infections in the world have declined, there are still regions that are geographically heterogenous that have reported an increase in infection rates. Additionally, some milestones for 2020 were missed, such as insufficient scaling up of treatment to reduce the number of new HIV infections.

    November 8, 2022
    General
    Pharmacy Times

  • South Africa To Begin Piloting Injectable PrEP in Early 2023

    South Africa is expected to begin piloting injectable pre-exposure prophylaxis (PrEP) in 2023, health financing mechanism Unitaid tells aidsmap. The demonstration study will be the first of many hoping to answer the single biggest challenge for a rollout there and beyond: How to take a surprisingly complicated injection out of clinics and hospitals and into communities.

    November 7, 2022
    PrEP
    aidsmap

  • Democratic Governor Signs Law Punishing HIV Transmission With Up to 10 Years in Prison

    Pennsylvania’s Gov. Tom Wolf (D) just signed a new law that makes it a felony to pass on a communicable disease when they “should have known” that they had it, the HIV Justice Network reported. Opponents of the law worry it will be used to punish people with HIV or other STDs who unknowingly transmit it to sexual partners. Such HIV criminalization laws have disproportionately been used to target Black men and other men of color.

    November 6, 2022
    General
    LGBTQ Nation

  • We Are Wasting Our Most Valuable Resource in the Fight Against HIV

    PrEP is one of the best tools we have at our disposal to end HIV transmission. Studies have shown that, when taken as prescribed, it reduces the risk of getting HIV by 99 per cent. As gay and bisexual men use PrEP more and more widely, we’ve also seen a sharp drop in new diagnoses among this population. The efficacy of PrEP is beyond debate. Yet despite its boundless potential, navigating the path to get this trailblazing drug to all who need it has been fraught with challenges.

    November 6, 2022
    PrEP
    Independent

  • HIV Activist Giulio Maria Corbelli Has Died

    It is with immense sadness we are sharing the news that Giulio Maria Corbelli, HIV activist and member of EATG, has died. This is a very sad day for the EATG family and Giulio’s loved ones. We are mourning the passing of a great friend and colleague, a tireless and dedicated HIV and LGBTI activist. His contribution in EATG’s work has been pivotal.

    November 6, 2022
    General
    European AIDS Treatment Group

  • Meet the Gay Doctor Answering the Questions You’re Too Shy To Ask Your Physician

    A gay doctor has earned a huge fanbase with his no-nonsense, straightforward videos about anal sex and sexually-transmitted infections. His following really exploded over the summer when he began to post videos specifically educating gay men about monkeypox.

    November 5, 2022
    General
    Queerty

  • PrEP Advocate Damon L. Jacobs Gets Real (and Naked) in Splashy Web Series

    “What do you like about your body?” That’s typically one of the first questions that therapist, life coach, author, PrEP promoter, and longtime HIV activist Damon L. Jacobs asks his guests on his YouTube show, Tub Talks With Damon L. Jacobs. This query is posed while Jacobs and his guests (mostly men, but sometimes women, too) are naked and sitting inches from each other in a sudsy bathtub.

    November 4, 2022
    PrEP
    Plus Magazine

Published Research

Announcements